11:30 AM - 11:45 AM (EDT), Tuesday, June 6, 2023 ・ Session Room 104B
Merck has a strong history of success in translating cutting-edge research into life-saving medical breakthroughs. Our scientific advances have made a difference in the lives of millions of patients worldwide.  From Merck’s development of the first measles and mumps vaccines to treatments for cancer and diabetes, we are an industry leader in bringing forth innovative new medicines. We operate in more than 140 countries and had sales of more than $48 billion in 2022. Merck recognizes that building partnerships is one of our most important jobs. We have BD professionals based in key innovation epicenters including Boston, San Francisco, London, Shanghai, Tokyo and our headquarters in Rahway, NJ. 
We’re pursuing the most innovative areas in biomedical research emerging today without regard to therapeutic area or modality and working on collaborations from discovery to clinical-stage programs.
Company Type:
Publicly Traded Company
Company Website:
Company HQ State:
Company HQ Country:
United States
Year Founded:
Main Therapeutic Focus:
Multiline Global Biopharma
Lead Product in Development:
Development Phase of Primary Product:
Multiple Products in Market
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
VP and Head, Boston & European Innovation Hubs & Discovery Transactions, BD&L